290 related articles for article (PubMed ID: 25446374)
1. Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment.
Luciano RL; Perazella MA
Drug Saf; 2015 Jan; 38(1):55-64. PubMed ID: 25446374
[TBL] [Abstract][Full Text] [Related]
2. Is aristolochic acid nephropathy a widespread problem in developing countries? A case study of Aristolochia indica L. in Bangladesh using an ethnobotanical-phytochemical approach.
Michl J; Jennings HM; Kite GC; Ingrouille MJ; Simmonds MS; Heinrich M
J Ethnopharmacol; 2013 Aug; 149(1):235-44. PubMed ID: 23806867
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pathological spectrums of aristolochic acid nephropathy.
Chen D; Tang Z; Luo C; Chen H; Liu Z
Clin Nephrol; 2012 Jul; 78(1):54-60. PubMed ID: 22732338
[TBL] [Abstract][Full Text] [Related]
4. Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date.
Cosyns JP
Drug Saf; 2003; 26(1):33-48. PubMed ID: 12495362
[TBL] [Abstract][Full Text] [Related]
5. Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up.
Lemy A; Wissing KM; Rorive S; Zlotta A; Roumeguere T; Muniz Martinez MC; Decaestecker C; Salmon I; Abramowicz D; Vanherweghem JL; Nortier J
Am J Kidney Dis; 2008 Mar; 51(3):471-7. PubMed ID: 18295063
[TBL] [Abstract][Full Text] [Related]
6. The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative review.
Gökmen MR; Cosyns JP; Arlt VM; Stiborová M; Phillips DH; Schmeiser HH; Simmonds MS; Cook HT; Vanherweghem JL; Nortier JL; Lord GM
Ann Intern Med; 2013 Mar; 158(6):469-77. PubMed ID: 23552405
[TBL] [Abstract][Full Text] [Related]
7. Aristolochic acid nephropathy and the peritoneum: Functional, structural, and molecular studies.
Gillerot G; Goffin E; Moulin P; Arlt VM; Phillips DH; Cosyns JP; Devuyst O
Kidney Int; 2003 Nov; 64(5):1883-92. PubMed ID: 14531824
[TBL] [Abstract][Full Text] [Related]
8. Aristolochic acid nephropathy: variation in presentation and prognosis.
Yang L; Su T; Li XM; Wang X; Cai SQ; Meng LQ; Zou WZ; Wang HY
Nephrol Dial Transplant; 2012 Jan; 27(1):292-8. PubMed ID: 21719716
[TBL] [Abstract][Full Text] [Related]
9. Possible role of mitochondrial injury in Caulis Aristolochia manshuriensis-induced chronic aristolochic acid nephropathy.
Liu X; Wu J; Wang J; Fan J; Feng X; Yu X; Yang X
Drug Chem Toxicol; 2017 Jan; 40(1):115-124. PubMed ID: 27250112
[TBL] [Abstract][Full Text] [Related]
10. [Aristolochic acid nephropathy ("Chinese herb nephropathy")].
Nortier J; Pozdzik A; Roumeguere T; Vanherweghem JL
Nephrol Ther; 2015 Dec; 11(7):574-88. PubMed ID: 26515658
[TBL] [Abstract][Full Text] [Related]
11. Long-term Outcome of Kidney Recipients Transplanted for Aristolochic Acid Nephropathy.
Kanaan N; Hassoun Z; Raggi C; Jadoul M; Mourad M; De Meyer M; Aydin S; Schmeiser HH; Cosyns JP; Goffin E
Transplantation; 2016 Feb; 100(2):416-21. PubMed ID: 26457602
[TBL] [Abstract][Full Text] [Related]
12. Update of aristolochic acid nephropathy in Korea.
Ban TH; Min JW; Seo C; Kim DR; Lee YH; Chung BH; Jeong KH; Lee JW; Kim BS; Lee SH; Choi BS; Han JS; Yang CW
Korean J Intern Med; 2018 Sep; 33(5):961-969. PubMed ID: 29551056
[TBL] [Abstract][Full Text] [Related]
13. [Case of traditional herbal medicine-induced aristolochic acid nephropathy developing to end-stage renal failure].
Fujimura T; Tamaki K; Iida S; Tanaka H; Ikedou H; Takamiya Y; Kato S; Tanaka A; Okuda S
Nihon Jinzo Gakkai Shi; 2005; 47(4):474-80. PubMed ID: 15971892
[TBL] [Abstract][Full Text] [Related]
14. [Nephropathy caused by Chinese plants and aristolochic acids: from clinical observation to experimental model].
Debelle F; Nortier J
Bull Mem Acad R Med Belg; 2006; 161(5):327-33. PubMed ID: 17283906
[TBL] [Abstract][Full Text] [Related]
15. [Aristolochic acid nephropathy: an issue worth more attention].
Liu XH; Yang X
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Apr; 33(4):554-8. PubMed ID: 23841283
[TBL] [Abstract][Full Text] [Related]
16. Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease.
Grollman AP
Environ Mol Mutagen; 2013 Jan; 54(1):1-7. PubMed ID: 23238808
[TBL] [Abstract][Full Text] [Related]
17. LC-MS- and (1)H NMR-Based Metabolomic Analysis and in Vitro Toxicological Assessment of 43 Aristolochia Species.
Michl J; Kite GC; Wanke S; Zierau O; Vollmer G; Neinhuis C; Simmonds MS; Heinrich M
J Nat Prod; 2016 Jan; 79(1):30-7. PubMed ID: 26706944
[TBL] [Abstract][Full Text] [Related]
18. Recognition of the toxicity of aristolochic acid.
Zhang HM; Zhao XH; Sun ZH; Li GC; Liu GC; Sun LR; Hou JQ; Zhou W
J Clin Pharm Ther; 2019 Apr; 44(2):157-162. PubMed ID: 30548302
[TBL] [Abstract][Full Text] [Related]
19. Aristolochic acid nephropathy: a worldwide problem.
Debelle FD; Vanherweghem JL; Nortier JL
Kidney Int; 2008 Jul; 74(2):158-69. PubMed ID: 18418355
[TBL] [Abstract][Full Text] [Related]
20. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).
Nortier JL; Martinez MC; Schmeiser HH; Arlt VM; Bieler CA; Petein M; Depierreux MF; De Pauw L; Abramowicz D; Vereerstraeten P; Vanherweghem JL
N Engl J Med; 2000 Jun; 342(23):1686-92. PubMed ID: 10841870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
